Organizing Committee Member

Dr. Serge Bottari

Dr. Serge Bottari

Professor
University Grenoble Alpes,
France

Biography

Serge Bottari, obtained his M.D. and his Ph.D. (Biochemistry) degrees at the Free University Brussels, Belgium. He specialized in OB/GYN and was a Post-Doctoral Fellow and Research Associate at UC San Francisco. After having been a project leader at Sandoz and CIBA-Geigy in Basle, Switzerland, he became Professor of Cell Biology at the Medical School and Head of Endocrine Biology at the University Hospital in Grenoble, France, in 1993. While still a medical student, he participated in the first purification of a G-protein coupled receptor (turkey erythrocyte ß-adrenergic receptor) to be reported in 1977. His first publication on structure-activity relationships of ß-adrenergic receptors appeared in 1979. His major contributions have been in the field of adrenergic and angiotensin receptors, in particular the AT2 receptor which he reported as one of the first GPCRs to activate tyrosine phosphatases and to regulate endothelial cell proliferation. He also participated in the development of the angiotensin AT1 receptor antagonist valsartan. He published numerous articles in premium journals and is member of several editorial boards and expert committees (INSERM, HCERES, HAS, Marie Curie COFUND,…). His current work focuses among others on the molecular mechanisms involved in insulin-resistance, infertility, nitro-oxidative stress and on the development of novel diagnostic tools.

Research Area

Diabetes and endocrinology

Talk to Us

Speak directly to one of our conference representatives by calling.


+0044-2033180199

Mail Us

E-mail us your questions about the conference. We will respond to your questions.


contact@euroscicon.com

Contact Us

Have questions?
We'll be in touch within 24 hours.


Contact Us

Address

EuroSciCon Ltd
35 Ruddlesway,
Windsor, Berkshire,
SL4 5SF, UK

EuroSciCon Events are produced by Euroscicon Ltd

EuroSciCon, founded in 2001 is a UK based independent life science Events Company with predominantly business and academic client base. The key strategic objective of EuroSciCon is to communicate science and medical research between academia, clinical practice and the pharmaceutical industry. Most of its events are in Europe and London or live streamed. EuroSciCon expanded its operations to international in association with Meetings International, Singapore. All major meetings of EuroSciCon and Meetings International will issue Continued Professional Education (CPD), Continued Education (CE), Continued Medical Education (CME) Credits.